OrthoPediatrics Corp. (NASDAQ:KIDS) Insider Sells $133,224.74 in Stock

OrthoPediatrics Corp. (NASDAQ:KIDS) insider Gregory A. Odle sold 5,359 shares of the firm’s stock in a transaction dated Tuesday, March 18th. The shares were sold at an average price of $24.86, for a total value of $133,224.74. Following the transaction, the insider now directly owns 148,788 shares in the company, valued at $3,698,869.68. This trade represents a 3.48 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website.

OrthoPediatrics Stock Performance

OrthoPediatrics stock opened at $25.54 on Friday. The company has a current ratio of 7.17, a quick ratio of 3.68 and a debt-to-equity ratio of 0.19. The firm has a 50-day moving average of $24.84 and a 200-day moving average of $25.53. The firm has a market cap of $620.29 million, a P/E ratio of -20.76 and a beta of 1.22. OrthoPediatrics Corp. has a 1-year low of $21.02 and a 1-year high of $35.99.

OrthoPediatrics (NASDAQ:KIDS) last posted its earnings results on Tuesday, March 4th. The company reported ($0.29) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.33) by $0.04. OrthoPediatrics had a negative net margin of 15.00% and a negative return on equity of 5.78%. The company had revenue of $52.67 million during the quarter, compared to analyst estimates of $51.16 million. During the same period in the prior year, the business posted ($0.23) earnings per share. Sell-side analysts expect that OrthoPediatrics Corp. will post -0.93 EPS for the current year.

Institutional Trading of OrthoPediatrics

Several institutional investors and hedge funds have recently bought and sold shares of KIDS. Mutual of America Capital Management LLC lifted its holdings in OrthoPediatrics by 195.1% in the third quarter. Mutual of America Capital Management LLC now owns 107,609 shares of the company’s stock worth $2,917,000 after buying an additional 71,146 shares during the period. Quest Partners LLC lifted its holdings in OrthoPediatrics by 924.4% in the third quarter. Quest Partners LLC now owns 11,986 shares of the company’s stock worth $325,000 after buying an additional 10,816 shares during the period. Connor Clark & Lunn Investment Management Ltd. purchased a new stake in OrthoPediatrics in the third quarter worth about $295,000. Charles Schwab Investment Management Inc. lifted its holdings in OrthoPediatrics by 2.1% in the third quarter. Charles Schwab Investment Management Inc. now owns 132,434 shares of the company’s stock worth $3,590,000 after buying an additional 2,661 shares during the period. Finally, Quantbot Technologies LP lifted its holdings in OrthoPediatrics by 42.2% in the third quarter. Quantbot Technologies LP now owns 5,773 shares of the company’s stock worth $157,000 after buying an additional 1,712 shares during the period. 69.05% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of research analysts have recently issued reports on KIDS shares. Truist Financial reduced their price objective on OrthoPediatrics from $28.00 to $25.00 and set a “hold” rating on the stock in a research note on Wednesday, December 18th. Needham & Company LLC reaffirmed a “buy” rating and set a $42.00 price objective on shares of OrthoPediatrics in a research note on Wednesday, March 5th. Finally, Stifel Nicolaus reduced their price objective on OrthoPediatrics from $40.00 to $32.00 and set a “buy” rating on the stock in a research note on Wednesday, March 5th.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.